Benkun Zou
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A host enzyme reduces metabolic dysfunction-associated steatotic liver disease (MASLD) by inactivating intestinal lipopolysaccharide.
Journal: eLife
Published: April 24, 2025
Efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients with rare KRAS mutations: a real-world retrospective study.
Journal: Translational lung cancer research
Published: April 27, 2024
Alveolar epithelial cells shape lipopolysaccharide-induced inflammatory responses and reprogramming of alveolar macrophages.
Journal: European journal of immunology
Published: February 19, 2024
PEG2000-PLA-based nanoscale polymeric micelles reduce paclitaxel-related toxicity in beagle dogs.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 11, 2023
Acyloxyacyl hydrolase promotes pulmonary defense by preventing alveolar macrophage tolerance.
Journal: PLoS pathogens
Published: August 16, 2022
ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among TP53-Negative NSCLC Patients.
Journal: Frontiers in genetics
Published: June 11, 2021
A host lipase prevents lipopolysaccharide-induced foam cell formation.
Journal: iScience
Published: June 01, 2021
LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma.
Journal: The Journal of experimental medicine
Published: December 06, 2017
Acyloxyacyl hydrolase promotes the resolution of lipopolysaccharide-induced acute lung injury.
Journal: PLoS pathogens
Published: December 13, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026